
About

Op. Dr. Mehmet Fatih KARADAĞ
Eğitim:
-
YYÜ Tıp Fakültesi (2003-2008)
-
Hacettepe Üniversitesi Tıp Fakültesi (1996-2003)
Deneyim:
-
Gaziantep Liv Hospital Gaziantep (2026 - )
-
Dünyagöz Hastanesi Gaziantep Şube (2017-2026)
-
Lokman Hekim Hastanesi, İbni Sina Hastanesi (2010-2017)
-
Mecburi Hizmet Tatvan DH (2008-2010)
Ödüllerim:
-
International Council of Opthalmology Clinical Sciences (2011)
-
International Council of Opthalmology Basic Science (2011)
-
International Council of Opthalmology Optic and Refraction (2012)
-
Göz alanında uluslararası en üst düzey sınav olan ADVANCED ICO sınavını kazanarak FICO ünvanını aldı. (2018)
İİlgi Alanları:
-
Lazer Refraktif Cerrahi; No Touch- Intralase Lasik- Smile Cerrahisi
-
Vitreoretinal Cerrahi
-
Kök Hücre Tedavisi
-
Glokom Cerrahisi
-
Şaşılık Cerrahisi
-
Akıllı mercek & Fakik IOL
-
Keratokonus Tedavisi (CCL, Korneal Halka)
-
Komplike Katarakt Ameliyatları
-
Oküloplastik Cerrahi
-
Kanal tıkanıklığı tedavisi, DSR cerrahisi
-
Göz çevresi estetiği (Üst kapak sarkması, Alt kapak torbaları, Badem göz)
Articles Published in International Peer-Reviewed Journals
1.Karadağ MF, Abbas İnandırıcı M.’Ocular findings in patients with vitiligo: A singlecenter experience.’ J Fr Ophtalmol. 2022 Nov;45(9):1004-1011.
2.Karadağ MF. ‘’Evaluation of augmentation index and pulse wave velocity measurements in central retinal vein occlusion patients with and without hypertension’’. Int Ophthalmol. 2022 Jan 27.doi: 10.1007/s10792-022-02237-1
3.Karadağ MF ‘A new potential risk factor for central serous chorioretinopathy: blood pressure variability’’. Eye (Lond). 2021 Aug;35(8):2190-2195.
4.Karadağ MF. ‘Three-year results of combined pars plana vitrectomy and phacoemulsification in diabetic vitreous hemorrhage’. Journal of Health Sciences and Medicine,2022. 5(4), 1128-1132., Doi: 10.32322/jhsm.1129291
5.Karadağ MF.’Keratokonusta in Vivo Lazer Tarayıcı Konfokal Mikroskopi Bulguları’’ Aksaray Üniversitesi Tıp Bilimleri Dergisi ASUJMS, 2(3): 20-24
6.Timucin OB, M.F. Karadag, A. Cinal, "Assessment of keratocyte density in patients with keratoconus not using contact lenses.", Cornea (ISI) , 576-9 pp., 2011 , DOI: 10.1097/ICO.0b013e3182000fd4
7.M. Asker, O.B. Timucin, S. Asker, M.F. Karadag, "Effect of ramipril therapy on abnormal left atrial appendage function.", J Int Med Res (ISI) , 2429-35 pp., 2011
8.Timucin OB, M.F. Karadag, A.Cinal, M. Asker, S. Asker, D. Timucin, "Assessment of Corneal Endothelial Cell Density in Patients With Keratoconus Not Using Contact Lenses", Contact Lens and Anterior Eye (ISI) , 36 (2013) 80– 85, DOI: 10.1016/j.clae.2012.10.081
9.Timucin OB, Karadag MF, Aslanci ME, Baykara M. Toxic effect of methylene blue 1% on corneal endothelium and iris epithelium. Arquivos Brasileiros de Oftalmologia. 2016 Apr;79(2):121-2. doi: 10.5935/0004-2749.20160036.
10.Timucin OB, Karadag MF, Mehmet B. Contact lenses, migraine, and allodynia.Oman J Ophthalm. 2016;9:101-3
11.Timucin OB, Karadag MF, Baykara M, Aslanci ME Posterior Uveal Effusion Syndrome Following Ectopia Lentis Surgery in a Case with Marfan's Syndrome Pak J Ophthamol.2016: 32( 2)
12.Timucin OB,Mutlu EA,Timucin D,Aslancı ME,Işıklıgil I, Karadag MF, Ozbay EK. ‘Psychophysical assessment of koniocellular pathway in patients with schizophrenia versus healthy controls’. Psychiatry Res Neuroimaging. 2017 Aug 30;266:27-34.13.Timucin OB, Arabacı M,Cuce F, Karatas B,Onalan S,Yasar M, Yıldırım S, Karadag MF. ‘The effects of light sources with different spectral structures on ocular axial
Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitaplarında Basılan Bildiriler
B. Timucin, M. Baykara, M. F.Karadag, M. E. Aslanci, 15th ESCRS Winter Meeting konferansı dahilinde "Poster Abstracts Visual Optics" bildiri kitapçığındaki "Influence of Accommodation On The Corneal Vertex", 34 pp., İstanbul, Türkiye, Şubat 2011
O. B. Timucin, M. F.Karadag, 32. ESCRS kongresi dahilinde "Poster Abstracts Visual Optics" bildiri kitapçığındaki "Posterior uveal effusion syndrome following ectopia lentis surgery in a case with Marfan's syndrome", Londra, UK. 2014.
Ulusal Hakemli Dergilerde Yayımlanan Makaleler
F. Karadag.‘’Comparison of visual and refractive outcomes between femtosecond laser-assisted in situ keratomileusis (FS-LASIK) and photorefractive keratectomy (PRK): a long-term outcomes analysis’’ J Health Sci Med 2022; 5(1): 257-261
Yaşar, A.Kurt, A.Çınal,,F. Karadağ, A. Demirok,’’ Results of Latanoprost Therapy in Long-Term Follow Up’’ ,Journal of Glaucoma-Cataract, 2007, Volume 2, Number 4, 271-273.
Kılıç, A.Çınal, N.Karpuzoğlu, A. Gül, F. Karadağ, T. Yaşar, A. Demirok, ‘’Esotropyada Cerrahi Sonuçlarımız’’ Harran Üniversitesi Tıp Fakültesi Dergisi 2007;4(2):58-60
ÖB. Timuçin, O. Yılmaz, M. F. Karadağ, M. Aşker, S. Aşker, M. E. Aslancı, "Subkonjonktival Hemoraji: Sıklığı ve Klinik Özellikleri",Turk J Ophthalmol , 90-3 pp., 2011 , DOI: 10.4274/tjo.41.18
Timucin OB. Karadag MF Contact lenses as a migraine trigger. Agri. The Journal of The Turkish Society of Algology, 29(4), 185-187., Doi: 10.5505/agri.2016.71473
My Memberships
Turkish Ophthalmology Association
Turkish Medical Association (2015)
Our Mission
We believe that sight is not just a sense, but the deepest connection humans have with the world.
With this understanding, our mission is to provide every patient with safe, ethical, and personalized treatments using the latest scientific and technological advancements.
Our goal is not only to treat diseases, but also to improve quality of life by protecting eye health and enabling every individual to once again see a clear, comfortable world.
Dr. Mehmet Fatih Karadağ and his team view each patient not just as a case, but as a unique human story.
Therefore, every treatment plan is prepared with care, knowledge, and sincerity.
Our Vision
With scientifically based, innovative and human-centered approaches, it is a reference eye health center at national and international levels.
to be central.
Bringing together technology, research, and ethical responsibility in ophthalmology; fostering a continuously evolving culture of excellence in education, scientific production, and clinical practice.
We aim to create.
Our vision is to establish a lasting understanding of eye health where every patient feels safe, every colleague engages in scientific sharing, and science, humanity, and the future intersect.
